ShareProphets : keywords

IXI

IXICO – next year “expects to achieve double digit revenue growth”, but what about this year and the bottom-line?

Medical analytics company IXICO plc (IXI) has issued a trading update commencing that it “reconfirms its revenue expectations of £7 million for the year to 30 September 2023 and announces that it now expects to achieve double digit revenue growth in the year to 30 September 2024”. So what of this currently helping the shares up to 26.5p?

By Steve Moore
231 days ago

IXI

IXICO – “contract win”. Is it?, and what about the contract loss and financial outlook?

Medical analytics company IXICO plc (IXI) has announced that it “has been selected by a leading global pharmaceutical company, and new client, to provide MRI imaging services for an early phase clinical trial”. So what’s the detail, with the shares currently up approaching 4% at 26.5p in response?

By Steve Moore
291 days ago

IXI

IXICO – “a strong set of financial results”, Really?

Medical analytics company IXICO plc (IXI) has announced what it emphasises as “a strong set of financial results… strong balance sheet supports the execution of our renewed five-year strategic plan”. So what of a share price response currently approaching 6% lower at 27.5p, to give a £13.2 million market cap?

By Steve Moore
293 days ago

IXI

IXICO – ahead of expectations, but set not to be so for long...

Medical analytics company IXICO plc (IXI) has announced results for its half-year ended 31st March 2022, including that it now anticipates that it will “materially exceed” market profit expectations for the full year. So what of a current 37.5p share price, down more than 9%?!...